A polymorphism in the integrin αV subunit gene affects the progression of primary biliary cirrhosis in Japanese patients
Background Accumulating evidence indicates that multiple genetic factors are involved in the pathogenesis of primary biliary cirrhosis (PBC). The aim of this study was to investigate whether polymorphisms of the integrin αV subunit gene ( ITGAV ), a component of integrin αVβ6, which plays an importa...
Gespeichert in:
Veröffentlicht in: | Journal of gastroenterology 2011-05, Vol.46 (5), p.676-686 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background
Accumulating evidence indicates that multiple genetic factors are involved in the pathogenesis of primary biliary cirrhosis (PBC). The aim of this study was to investigate whether polymorphisms of the integrin αV subunit gene (
ITGAV
), a component of integrin αVβ6, which plays an important role in the process of fibrosis, are associated with susceptibility to the onset and/or progression of PBC.
Methods
In the primary study, eight tag single nucleotide polymorphisms (SNPs) in
ITGAV
were analyzed by polymerase chain reaction (PCR)-restriction fragment length polymorphism, direct DNA sequencing, or high-resolution melting curve analysis in 309 Japanese patients with PBC who were registered in the National Hospital Organization Study Group for Liver Disease in Japan (PBC cohort I) and 293 gender-matched healthy Japanese volunteers (control subjects). For the replication study, 35 PBC patients who progressed to end-stage hepatic failure and underwent liver transplantation (PBC cohort II) were also analyzed.
Results
Three tag SNPs (rs3911238, rs10174098, and rs1448427) in
ITGAV
were significantly associated with the severe progression of PBC, but not with susceptibility to the onset of PBC, in the primary study (PBC cohort I). Among these SNPs, rs1448427 was also significantly associated with the severe progression to end-stage hepatic failure in the replication study of PBC patients who underwent liver transplantation (PBC cohort II).
Conclusions
ITGAV
is a genetic determinant for the severe progression of PBC in Japanese patients. Genetic polymorphisms of
ITGAV
may be useful for identifying high-risk Japanese PBC patients, including those who will require liver transplantation, at the time of initial diagnosis. |
---|---|
ISSN: | 0944-1174 1435-5922 |
DOI: | 10.1007/s00535-010-0351-0 |